Cosmo to bring real-time ai into intelligent medical devices with nvidia igx

Dublin, ireland--(newsfile corp. - june 3, 2024) - cosmo pharmaceuticals n.v. (six: copn) (fse: c43) (“cosmo”) with its cosmo intelligent medical devices division (“cosmo imd”) is consolidating its strategy to accelerate the adoption of responsible and regulated ai in healthcare, obtaining pragmatic results in its mission to address unmet clinical needs and improve patient outcomes.
NVDA Ratings Summary
NVDA Quant Ranking